Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes

BACKGROUND: Fibroblast growth factor 21 (FGF21), a glucose and lipid metabolic regulator, has recently been demonstrated to be associated with cardiovascular diseases (CVD) such as carotid atherosclerosis, coronary heart disease and carotid artery plaques. However, the relationship between circulati...

詳細記述

保存先:
書誌詳細
出版年:Cardiovasc Diabetol
主要な著者: Xiao, Yang, Liu, Lingjiao, Xu, Aimin, Zhou, Pengcheng, Long, Zhaofeng, Tu, Yiting, Chen, Xiaoyan, Tang, Weili, Huang, Gan, Zhou, Zhiguang
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2015
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4475300/
https://ncbi.nlm.nih.gov/pubmed/26047614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-015-0229-9
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料